Final Exam Flashcards
principal endogenous estrogen
estradiol
principal progestational hormone
progesterone
days 1-14 of cycle
follicular phase, dominated by estrogen
days 14-28 of cycle
luteal phase, dominated by progesterone
raloxifene effects on bone density, breast cancer, CV, & uterine cancer
raloxifene- SERM
positive effects on bone density and breast cancer risk
increases risk of CV events
does not increase risk of uterine cancer
estrogen/bazedoxifine
combined estrogen and estrogen receptor agonist/antagonist
prescribed for vasomotor symptoms, osteoporosis prevention
PROTECTS ENDOMETRIUM
effects of adding progestin to HRT
protects against endometrial cancer
stimulates breast cancer risk
depression
breast tenderness
Women who still have a uterus must have what added to their estrogen HRT therapy?
progestin
chlorphiramine
first gen antihistamine
clemastine
first gen antihistamine
fexofenadine (allegra)
second generation antihistamine
cetirizine
second generation antihistamine
budesonide
glucocorticoid drug for asthma
fluticasone
glucocorticoid drug for asthma
adverse effects of inhaled glucocorticoid therapy for asthma
dysphonia and oropharyngeal candidiasis
Montelukast
leukotriene modifier for asthma
oral administration
cromolyn
used for prophylaxis of asthma symptoms. Suppresses inflammation.
principal bronchodilators in asthma treatment
Beta 2 adrenergic agonists-
salmeterol
longer-acting beta agonist for asthma treatment. Not effective for immediate rescue therapy.
adverse effects of beta2 adrenergic agonists
tachycardia, angina, tremor— dose dependent, should not occur unless pt is overdosing on inhaler.
fluticasone/salmeterol and budesonide
glucocorticoid/LABA combinations for long-term asthma maintenance in adults and children who have failed treatment with SABA. LABA should never be taken alone- should always be taken with glucocorticoid
How long to wait between 2 puffs of beta agonist? How much to wait between SABA and glucocorticoid?
1 minute between puffs of albuterol
5 minutes between SABA and glucocorticoid
Therapy of severe asthma exacerbations
oxygen
systemic, IV glucocorticoid
nebulized high-dose SABA
nebulized ipratropium (anticholinergic med) to reduce airflow obstruction
ipratropium
anticholinergic receptor that further reduces bronchoconstriction in acute asthma exacerbations
Adverse effects: dry mouth, irritation of pharynx, increase in eye pressure in those with glaucoma, and rare possible CV events.